Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 743585
                    [Title] => Roche launches  drug for advanced  ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-03 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. GIL GONZALEZ

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 743585
                    [Title] => Roche launches  drug for advanced  ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-03 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Roche launches drug for advanced ovarian cancer

November 3, 2011 - 12:00am

Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.

Science and Environment